SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-005463
Filing Date
2014-11-12
Accepted
2014-11-12 06:36:53
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atra-10q_20140930.htm 10-Q 2018882
2 EX-31.1 atra-ex311_20140930219.htm EX-31.1 14224
3 EX-31.2 atra-ex312_20140930220.htm EX-31.2 14368
4 EX-32.1 atra-ex321_20140930221.htm EX-32.1 7750
  Complete submission text file 0001564590-14-005463.txt   10639308

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT atra-20140930.xml EX-101.INS 1928559
6 XBRL TAXONOMY EXTENSION SCHEMA atra-20140930.xsd EX-101.SCH 41557
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atra-20140930_cal.xml EX-101.CAL 33401
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atra-20140930_def.xml EX-101.DEF 213864
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20140930_lab.xml EX-101.LAB 365343
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20140930_pre.xml EX-101.PRE 306560
Mailing Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005 415-287-2410
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36548 | Film No.: 141210948
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences